AbbVie ABBV
NYSE ABBV
$265.63 +3.80 (+1.45%)
As of: Aug 21, 2026 · 10:46 AM EDT

AbbVie (ABBV) FCF Margin (2012 - 2026)

AbbVie (ABBV) posted quarterly FCF Margin of 23.76% for Q1 2026, up 1326.0% year-over-year from 1.67% in Q1 2025, and down 19.25% quarter-over-quarter from 29.42% in Q4 2025.

AbbVie (ABBV) FCF Margin (2012 - 2026) Analysis & Trends

AbbVie (ABBV) has reported FCF Margin for 15 consecutive years, with 23.76% the latest figure, recorded in Q1 2026.

  • In Q1 2026, FCF Margin rose 1326.0% year-over-year to 23.76%; the TTM figure through Mar 2026 stood at 31.81% (up 499.0% YoY), while the FY2025 annual figure was 29.13%, down 252.0% from the prior year.
  • FCF Margin retreated to 23.76% in Q1 2026 per ABBV's latest filing, from 29.42% in the prior quarter.
  • Across five years, FCF Margin topped out at 52.81% in Q3 2023 and bottomed at 10.49% in Q1 2025.
  • Historically, FCF Margin has averaged 34.79% across 5 years, with a median of 33.34% in 2022.
  • Annual changes were most pronounced in 2024 — FCF Margin plunged 3025 bps — and 2025, when it surged 1763 bps.
  • AbbVie's FCF Margin stood at 47.72% in 2022, then plunged by 33 bps to 31.8% in 2023, then surged by 41 bps to 44.74% in 2024, then sank by 34 bps to 29.42% in 2025, then declined by 19 bps to 23.76% in 2026.
  • Business Quant data shows ABBV's FCF Margin at 23.76% in Q1 2026, 29.42% in Q4 2025, and 42.11% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 652.29 Bn 631.53 Bn 17.26 Bn 28.82%
2 AbbVie 470.14 Bn 463.57 Bn 12.70 Bn 18.33%
3 Merck 379.19 Bn 372.05 Bn 12.21 Bn 26.96%
4 Novartis Ag 302.86 Bn 295.17 Bn 11.24 Bn 38.60%
5 Astrazeneca 257.65 Bn 252.75 Bn 12.86 Bn -12.07%
6 Amgen 236.75 Bn 222.76 Bn 7.24 Bn 34.70%
7 Gilead Sciences 182.65 Bn 179.47 Bn 6.22 Bn 44.00%
8 Pfizer 161.71 Bn 150.01 Bn 10.94 Bn 2.01%
9 Gsk 105.55 Bn 101.38 Bn 8.24 Bn 3.90%
10 Sanofi 55.07 Bn 47.69 Bn 10.79 Bn 18.92%

Historic Data

Download Data
DateValue
Jun 30, 2026 18.33%
Mar 31, 2026 23.76%
Dec 31, 2025 29.42%
Sep 30, 2025 42.11%
Jun 30, 2025 31.67%
Mar 31, 2025 10.49%
Dec 31, 2024 44.74%
Sep 30, 2024 35.95%
Jun 30, 2024 14.04%
Mar 31, 2024 31.25%
Dec 31, 2023 31.80%
Sep 30, 2023 52.81%
Jun 30, 2023 44.29%
Mar 31, 2023 32.87%
Dec 31, 2022 47.72%
Sep 30, 2022 50.13%
Jun 30, 2022 33.34%
Mar 31, 2022 35.06%
Dec 31, 2021 32.84%
Sep 30, 2021 53.81%